Day: 30 July 2019

Original

PredictImmune secures £10 million Series B investment led by BGF

PredictImmune closes Series B funding round, raising £10M to further accelerate global commercial expansion and support expanding product pipeline New and existing investors demonstrate strong confidence in the developer of unique and pioneering prognostic tools to guide treatment of patients with immune-mediated diseases Cambridge, UK, 30 July: PredictImmune, developers of pioneering prognostic tools for guiding treatment […]Read More